Transitioned to Co-founder & CTO at Autodemia to spearhead core AI architecture and R&D

Sun, 01 Nov 2026 00:00:00 +0000

In November 2026, I transitioned from CEO to Co-founder & CTO at Autodemia.

In this role, I am dedicating my focus to leading our technical vision, core R&D, and engineering execution—advancing our multi-agent research engine (AutoRes), scientific visualization pipeline (FigShot), and next-generation trustworthy infrastructure for AI Auto Research and AI Auto Engineering.

Co-founded Autodemia as CEO to build trustworthy AI infrastructure for autonomous research

Fri, 01 May 2026 00:00:00 +0000

In May 2026, I co-founded Autodemia and served as its CEO, embarking on an entrepreneurial journey to build trustworthy, programmable AI infrastructure for autonomous scientific research and engineering.

At Autodemia, we integrate multi-agent collaboration architectures, domain knowledge bases, compute scheduling, and multi-model routing into a unified system for scientific discovery, featuring core products such as:

AutoRes: A flagship AI-autonomous research platform that orchestrates agents across literature review, hypothesis formulation, experiment execution, data analysis, and scientific reporting.
FigShot: An AI data analysis and scientific visualization assistant that transforms raw experimental data and sketches into publication-ready figures.

Autodemia | Borui Kang

Transitioned to Co-founder & CTO at Autodemia to spearhead core AI architecture and R&D

Co-founded Autodemia as CEO to build trustworthy AI infrastructure for autonomous research